News
March 8, 2023 News
Report launch: The Swedish Drug Discovery and Development Pipeline 2023
SwedenBIO launches the long-awaited 2023 edition of the large, recurring mapping of the Swedish pharmaceutical pipeline.
February 8, 2023 News
Oblique Therapeutics offentliggör utfall i genomförd företrädesemission
January 4, 2023 News
Announcement of Oblique Therapeutics ‘s Rights Issue 2023
November 9, 2022 News
Oblique Therapeutics is pleased to announce the nomination of Christer Nordstedt M.D. Ph.D. as Chief Executive Officer
the new CEO will assume the position on 1st December 2022.
July 28, 2022 News
REKRYTERING AV NY VD
July 8, 2022 News
North Point Securities agerade finansiell rådgivare i samband med
Oblique Therapeutics AB (publ.) Private Placement om cirka 28 MSEK.
July 1, 2022 News
Oblique Therapeutics offentliggör utfall i företrädesemission av tvingande konvertibler
June 23, 2022 News
Protocol from the Annual General Meeting 15th June 2022
Protokoll från årsstämma 2022 - Protocol from the Annual General Meeting 15th June 2022
June 15, 2022 News
Release from the Annual General Meeting 15th June 2022
Kommuniké från årsstämma 2022 - Release from the Annual General Meeting 15th June 2022
June 2, 2022 News
Just out – Oblique Therapeutics AB Annual Report for 2021.
Follow the link to get access to the report 2021